Assembly Biosciences, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $425.00K, a 19.05% increase year-over-year.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $368.00K, a 287.37% increase year-over-year.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $357.00K, a 549.09% increase year-over-year.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $725.00K, a 383.33% increase from fiscal 2024.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $150.00K, a 16.28% increase from fiscal 2023.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $129.00K, a 55.36% decline from fiscal 2022.
- Assembly Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $289.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $425.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $368.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $725.00K 10-K · filed 2026-03-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2025-06-30 | $357.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $150.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2024-06-30 | $55.00K 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $129.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2023-06-30 | $80.00K 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $289.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | |
| 2022-06-30 | $177.00K 10-Q · filed 2023-08-09 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2021-06-30 | $144.00K 10-Q · filed 2022-08-09 | |
| 2018-12-31 | $408.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |